APO Research
Talk to an analyst

APO RESEARCH · REPORT

Esketamine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Esketamine Market Outlook and Growth Opportunities 2026

22 December 2025193 pages

Choose your research edition.

Industry ResearchEsketamine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Esketamine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Esketamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Esketamine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Esketamine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Esketamine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Esketamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Esketamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Esketamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Esketamine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Esketamine market include Janssen Pharmaceutica, Merck, PFIZER, Medkoo and Endo International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Esketamine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Esketamine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Esketamine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Esketamine market size, projected growth trends, production technologies, key applications, and end-use industries.

Esketamine Segment by Company

Janssen Pharmaceutica

Merck

PFIZER

Medkoo

Endo International

Esketamine Segment by Type

Injection

Oral Medications

Nasal Spray

Esketamine Segment by Application

General Anesthetic

Treatment-resistant Depression

Esketamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Esketamine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Esketamine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Esketamine significant trends, drivers, influence factors in global and regions.

6. To analyze Esketamine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Esketamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Esketamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Esketamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Esketamine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Esketamine industry.

Chapter 3: Detailed analysis of Esketamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Esketamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Esketamine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Esketamine Industry Trends Table 2. Esketamine Industry Drivers Table 3. Esketamine Industry Opportunities and Challenges Table 4. Esketamine Industry Restraints Table 5. Global Esketamine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Esketamine Revenue Share by Company (2021-2026) Table 7. Global Esketamine Sales Volume by Company (k units) & (2021-2026) Table 8. Global Esketamine Sales Volume Share by Company (2021-2026) Table 9. Global Esketamine Average Price (US$/unit) of Company (2021-2026) Table 10. Global Esketamine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Esketamine Key Company Manufacturing Base & Headquarters Table 12. Global Esketamine Company, Product Type & Application Table 13. Global Esketamine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Esketamine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Table 18. Significant Companies of Oral Medications Table 19. Significant Companies of Nasal Spray Table 20. Global Esketamine Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Esketamine Sales Volume by Type (2021-2026) & (k units) Table 22. Global Esketamine Sales Volume by Type (2027-2032) & (k units) Table 23. Global Esketamine Sales Volume Share by Type (2021-2026) Table 24. Global Esketamine Sales Volume Share by Type (2027-2032) Table 25. Global Esketamine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Esketamine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Esketamine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Esketamine Sales Value Share by Type (2021-2026) Table 29. Global Esketamine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of General Anesthetic Table 31. Significant Companies of Treatment-resistant Depression Table 32. Global Esketamine Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Esketamine Sales Volume by Application (2021-2026) & (k units) Table 34. Global Esketamine Sales Volume by Application (2027-2032) & (k units) Table 35. Global Esketamine Sales Volume Share by Application (2021-2026) Table 36. Global Esketamine Sales Volume Share by Application (2027-2032) Table 37. Global Esketamine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Esketamine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Esketamine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Esketamine Sales Value Share by Application (2021-2026) Table 41. Global Esketamine Sales Value Share by Application (2027-2032) Table 42. Global Esketamine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Esketamine Sales by Region (2021-2026) & (k units) Table 44. Global Esketamine Sales Market Share by Region (2021-2026) Table 45. Global Esketamine Sales by Region (2027-2032) & (k units) Table 46. Global Esketamine Sales Market Share by Region (2027-2032) Table 47. Global Esketamine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Esketamine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Esketamine Sales Value Share by Region (2021-2026) Table 50. Global Esketamine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Esketamine Sales Value Share by Region (2027-2032) Table 52. Global Esketamine Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Esketamine Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Esketamine Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Esketamine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Esketamine Sales by Country (2021-2026) & (k units) Table 57. Global Esketamine Sales Market Share by Country (2021-2026) Table 58. Global Esketamine Sales by Country (2027-2032) & (k units) Table 59. Global Esketamine Sales Market Share by Country (2027-2032) Table 60. Global Esketamine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Esketamine Sales Value Market Share by Country (2021-2026) Table 62. Global Esketamine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Esketamine Sales Value Market Share by Country (2027-2032) Table 64. Janssen Pharmaceutica Company Information Table 65. Janssen Pharmaceutica Business Overview Table 66. Janssen Pharmaceutica Esketamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Janssen Pharmaceutica Esketamine Product Portfolio Table 68. Janssen Pharmaceutica Recent Development Table 69. Merck Company Information Table 70. Merck Business Overview Table 71. Merck Esketamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Merck Esketamine Product Portfolio Table 73. Merck Recent Development Table 74. PFIZER Company Information Table 75. PFIZER Business Overview Table 76. PFIZER Esketamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. PFIZER Esketamine Product Portfolio Table 78. PFIZER Recent Development Table 79. Medkoo Company Information Table 80. Medkoo Business Overview Table 81. Medkoo Esketamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Medkoo Esketamine Product Portfolio Table 83. Medkoo Recent Development Table 84. Endo International Company Information Table 85. Endo International Business Overview Table 86. Endo International Esketamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Endo International Esketamine Product Portfolio Table 88. Endo International Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Esketamine Distributors List Table 92. Esketamine Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Esketamine Product Image Figure 2. Global Esketamine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Esketamine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Esketamine Sales (2021-2032) & (k units) Figure 5. Global Esketamine Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Esketamine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Image Figure 10. Oral Medications Image Figure 11. Nasal Spray Image Figure 12. Global Esketamine Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Esketamine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Esketamine Sales Volume Share by Type (2021-2032) Figure 15. Global Esketamine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Esketamine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Esketamine Sales Value Share by Type (2021-2032) Figure 18. General Anesthetic Image Figure 19. Treatment-resistant Depression Image Figure 20. Global Esketamine Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Esketamine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Esketamine Sales Volume Share by Application (2021-2032) Figure 23. Global Esketamine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Esketamine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Esketamine Sales Value Share by Application (2021-2032) Figure 26. Global Esketamine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Esketamine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Esketamine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Esketamine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Esketamine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Esketamine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Esketamine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Esketamine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Esketamine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Esketamine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Esketamine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Esketamine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Esketamine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Esketamine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Esketamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Esketamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Esketamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Esketamine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Esketamine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Oral Medications
  • Nasal Spray
Applications
  • General Anesthetic
  • Treatment-resistant Depression
Companies covered
  • Janssen Pharmaceutica
  • Merck
  • PFIZER
  • Medkoo
  • Endo International

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Esketamine Sales Value (2021-2032)
  4. 1.2.2 Global Esketamine Sales Volume (2021-2032)
  5. 1.2.3 Global Esketamine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Esketamine Market Dynamics
  1. 2.1 Esketamine Industry Trends
  2. 2.2 Esketamine Industry Drivers
  3. 2.3 Esketamine Industry Opportunities and Challenges
  4. 2.4 Esketamine Industry Restraints
3 Esketamine Market by Company
  1. 3.1 Global Esketamine Company Revenue Ranking in 2025
  2. 3.2 Global Esketamine Revenue by Company (2021-2026)
  3. 3.3 Global Esketamine Sales Volume by Company (2021-2026)
  4. 3.4 Global Esketamine Average Price by Company (2021-2026)
  5. 3.5 Global Esketamine Company Ranking (2024-2026)
  6. 3.6 Global Esketamine Company Manufacturing Base and Headquarters
  7. 3.7 Global Esketamine Company Product Type and Application
  8. 3.8 Global Esketamine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Esketamine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Esketamine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Esketamine Market by Type
  1. 4.1 Esketamine Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Oral Medications
  4. 4.1.3 Nasal Spray
  5. 4.2 Global Esketamine Sales Volume by Type
  6. 4.2.1 Global Esketamine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Esketamine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Esketamine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Esketamine Sales Value by Type
  10. 4.3.1 Global Esketamine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Esketamine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Esketamine Sales Value Share by Type (2021-2032)
5 Esketamine Market by Application
  1. 5.1 Esketamine Application Introduction
  2. 5.1.1 General Anesthetic
  3. 5.1.2 Treatment-resistant Depression
  4. 5.2 Global Esketamine Sales Volume by Application
  5. 5.2.1 Global Esketamine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Esketamine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Esketamine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Esketamine Sales Value by Application
  9. 5.3.1 Global Esketamine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Esketamine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Esketamine Sales Value Share by Application (2021-2032)
6 Esketamine Regional Sales and Value Analysis
  1. 6.1 Global Esketamine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Esketamine Sales by Region (2021-2032)
  3. 6.2.1 Global Esketamine Sales by Region: 2021-2026
  4. 6.2.2 Global Esketamine Sales by Region (2027-2032)
  5. 6.3 Global Esketamine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Esketamine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Esketamine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Esketamine Sales Value by Region (2027-2032)
  9. 6.5 Global Esketamine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Esketamine Sales Value (2021-2032)
  12. 6.6.2 North America Esketamine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Esketamine Sales Value (2021-2032)
  15. 6.7.2 Europe Esketamine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Esketamine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Esketamine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Esketamine Sales Value (2021-2032)
  21. 6.9.2 South America Esketamine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Esketamine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Esketamine Sales Value Share by Country, 2025 VS 2032
7 Esketamine Country-level Sales and Value Analysis
  1. 7.1 Global Esketamine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Esketamine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Esketamine Sales by Country (2021-2032)
  4. 7.3.1 Global Esketamine Sales by Country (2021-2026)
  5. 7.3.2 Global Esketamine Sales by Country (2027-2032)
  6. 7.4 Global Esketamine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Esketamine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Esketamine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Esketamine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Esketamine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Esketamine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Esketamine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Esketamine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Esketamine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Esketamine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Esketamine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Esketamine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Esketamine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Esketamine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Esketamine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Esketamine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Esketamine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Esketamine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Esketamine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Esketamine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Esketamine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Esketamine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Esketamine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Esketamine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Esketamine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Esketamine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Esketamine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Esketamine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Esketamine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Esketamine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Esketamine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Esketamine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Esketamine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Esketamine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Esketamine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Esketamine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Esketamine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Esketamine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Esketamine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Esketamine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Esketamine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Esketamine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Esketamine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Esketamine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Esketamine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Esketamine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Esketamine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Esketamine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Esketamine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Esketamine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Esketamine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Esketamine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Esketamine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Esketamine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Esketamine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Esketamine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Esketamine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Esketamine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Esketamine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Esketamine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Esketamine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Esketamine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Esketamine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Esketamine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Esketamine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Esketamine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Esketamine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Esketamine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Esketamine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Esketamine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Esketamine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Esketamine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Esketamine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Esketamine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Esketamine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Esketamine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Esketamine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Esketamine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Esketamine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Esketamine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Esketamine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Esketamine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Esketamine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Esketamine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Esketamine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Esketamine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Esketamine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Janssen Pharmaceutica
  2. 8.1.1 Janssen Pharmaceutica Company Information
  3. 8.1.2 Janssen Pharmaceutica Business Overview
  4. 8.1.3 Janssen Pharmaceutica Esketamine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Janssen Pharmaceutica Esketamine Product Portfolio
  6. 8.1.5 Janssen Pharmaceutica Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Esketamine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Esketamine Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 PFIZER
  14. 8.3.1 PFIZER Company Information
  15. 8.3.2 PFIZER Business Overview
  16. 8.3.3 PFIZER Esketamine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 PFIZER Esketamine Product Portfolio
  18. 8.3.5 PFIZER Recent Developments
  19. 8.4 Medkoo
  20. 8.4.1 Medkoo Company Information
  21. 8.4.2 Medkoo Business Overview
  22. 8.4.3 Medkoo Esketamine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Medkoo Esketamine Product Portfolio
  24. 8.4.5 Medkoo Recent Developments
  25. 8.5 Endo International
  26. 8.5.1 Endo International Company Information
  27. 8.5.2 Endo International Business Overview
  28. 8.5.3 Endo International Esketamine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Endo International Esketamine Product Portfolio
  30. 8.5.5 Endo International Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Esketamine Value Chain Analysis
  2. 9.1.1 Esketamine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Esketamine Sales Mode & Process
  6. 9.2 Esketamine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Esketamine Distributors
  9. 9.2.3 Esketamine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst